Michael “Red” Nazarian
Michael Nazarian, CEO. Michael has 10+ years of professional cultivation experience in the California Cannabis industry. Accomplishments include first of their kind granted utility patents for THCV cultivars, advised the Peruvian National Agricultural University of La Molina (UNALM) on development and SOP’s for their upcoming Cannabis Agricultural Research program, as well as working directly alongside dedicated partners in the search for, and development of, highly efficacious and robust genetics of THCV-rich Chemovars.

Michael has contributed first-hand to the development of our THCV-producing cultivars since before the federal THCV testing standard was released in 2016; the result has been the World’s first (3) granted utility patents on THCV cultivars. In 2022 Michael was contracted to compose a 100+ page internal advisory document for UNALM for background and best practices in conducting agricultural Cannabis research. Through regenerative agricultural practices and utilizing solely traditional breeding methods thus far, Michael and the team have produced seed-stock and clonal chemovars that are undeniably robust in their capabilities to root and flower in any environment. These cultivars have progressed a long way over the years, having enhanced overall THCV production, increased the THCV:THC ratio to upwards of 2:1 in final flower, increased floral production, decreased flowering times, and maintained the landrace vigor and massive root structure of the original Malawi V cultivars.
Michael states “One of my proudest accomplishments is that we personally know individuals that have effectively used our THCV flowers to: treat their mental disorders; address obesity (massive reduction in visceral fat); cure an antibiotic resistant skin abscess, and treat depression. Not to forget that recreationally, our THCV chemovars have been described as ‘energetic and clarifying’, a ‘True Sativa’, ‘working weed’, and reported effects like ‘I get absolutely zero paranoia, and I never raid the fridge’. This is a really different type of cannabis from what’s currently available to the public.”